Global Cartilage Repair Market Overview:
Cartilage is a connective tissue that is present in many parts of the body, which is a tough and flexible material, it is relatively easy to damage. Around 65–80% of cartilage is water and the rest is a gel-like substance called the ‘matrix’ that gives it its form and function. Cartilage has several functions, comprising holding bones together and supporting other tissues. Decreases friction and acts as a cushion between joints and helps support the weight while running, bending and stretching. Patients with damage to the cartilage in a joint experiences inflammation, stiffness and range limitation. Cartilage repair and regeneration is a treatment for joints that have injured cartilage but are otherwise healthy.
Market Drivers
- Increase in Prevalence of Osteoarthritis (OA)
- Rising Prevalence of Diabetes and Obesity
Market Trend
- Technological Advancements in Cartilage Regeneration
- Growing Trend of Sports Activities and Outdoor Events
Restraints
- Availability of Different Treatment Options
Opportunities
- Limitations Associated With Current Surgical Techniques
Challenges
- High Costs of Knee Cartilage Repair Procedure
Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies.
Some of the key players profiled in the report are Arthrex, Inc. (United States), B. Braun Melsungen (Germany), Conmed Corporation (United States), Osiris Therapeutics, Inc. (United States), Collagen Solutions PLC (United Kingdom), CellGenix GmbH (Germany), BioTissue Technologies GmbH (Germany), RTI Surgical, Inc. (United States), Smith & Nephew PLC (United Kingdom) and Geistlich Pharma AG (Switzerland). Additionally, following companies can also be profiled that are part of our coverage like Orteq (United Kingdom) and Anika Therapeutics S. R. L. (United States). Analyst at AdvanceMarketAnalytics see United States and United Kingdom Players to retain maximum share of Global Cartilage Repair market by 2024. Considering Market by Treatment, the sub-segment i.e. Autologous Chondrocyte Transplantation (ACI) will boost the Cartilage Repair market. Considering Market by Causes, the sub-segment i.e. Injury or Trauma will boost the Cartilage Repair market.
Market Highlights:
February 11, 2019: CONMED Corporation announced that it has completed its previously announced acquisition of privately-held Buffalo Filter LLC (Buffalo Filter) from Filtration Group. Buffalo Filter is the market leader in surgical smoke evacuation technologies. and April 17, 2019: Osiris Therapeutics, Inc., a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced today that it has completed the previously announced sale of Osiris to Smith & Nephew plc (“Smith & Nephew”).
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Cartilage Repair market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Cartilage Repair market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Service Provider of Cartilage Repair, Healthcare Industry, Research Organization and Institutions, Research and Consulting Firms and Governmental Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.